Related Experiment Video
Updated: May 14, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Recent progress in small-molecule targeted therapies for melanoma treatment
Xinrui Yuan1, Hongyan Xu1, Yifeng Pei2
1School of Pharmacy, Jiangsu University, 301 Xuefu Road, Zhenjiang 212000, PR China.
None:
Melanoma is an aggressive form of skin cancer that originates from melanocytes and has a high risk of metastasis to distant organs. The identification of specific mutations and the subsequent development of targeted therapies have revolutionized the landscape of small-molecule drugs for melanoma. However, the acquired resistance and low response in a subset of melanoma patients promote continued research and clinical study for novel small-molecule targeted therapies. In recent years, several innovative targeted therapies and small-molecule strategies have been explored, which provide more options for melanoma patients. This review will summarize recent advances in targeted therapy for melanoma, with a focus on emerging small-molecule strategies and an update on their clinical progress.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Tumor Immunotherapy

